Home » Topics » BioWorld Science

BioWorld Science
RSS

ContraFect begins dosing in phase III study of exebacase for S. aureus bacteremia

Jan. 13, 2020

AKCEA-TTR-LRx begins phase III cardiovascular outcomes study

Jan. 13, 2020

Bio-Thera launches adalimumab biosimilar Qletli in China

Jan. 13, 2020

Xuanzhu (Hainan) Biopharmaceutical identifies farnesoid X receptor agonists

Jan. 13, 2020

New NRTK1 inhibitors disclosed by Beijing Innocare Pharmaceutical Technology

Jan. 13, 2020

Treatment effects may spread in LCA gene therapy

Jan. 13, 2020

Merck & Co. discovers PCSK9 inhibitors

Jan. 13, 2020

Amyloid after amnesia?

Jan. 13, 2020

FGF21 switches sides in pancreatitis

Jan. 13, 2020

Curadev Pharma synthesizes new STING agonists

Jan. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...